CHERISH Events

Conference Roundup: 2023 Annual Research Meeting

A curated list of appearances featuring CHERISH researchers.

June 24-27, 2023

2023 Academy Health Annual Research Meeting, Seattle, WA

Connect with CHERISH investigators, CHERISH Research Affiliates, Advisory Board members, and pilot grant recipients in person as they present their research at #ARM23.

Friday, June 23, 2023

  • Margaret Kuklinski, PhD, MA, University of Washington School of Social Work
    • Driving Tomorrow’s Outcomes Through Clinical Research in Real-World Settings: Essentials of Embedded Pragmatic Clinical Trials Workshop, 8:00 AM – 5:00 PM at 2AB (Level 2, Seattle Convention Center), Speakers

Saturday, June 24, 2023

  • Susan Busch, PhD, Yale School of Public Health
    • The Future of Mental Health and Substance Use Treatment Services in the United States, 12:30 PM – 2:00 PM PDT at 613-614 (Level 6, Seattle Convention Center), Panelist
  • Margaret Kuklinski, PhD, MA, University of Washington School of Social Work
    • Driving Tomorrow’s Outcomes Through Clinical Research in Real-World Settings: Essentials of Embedded Pragmatic Clinical Trials Workshop, 8:00 AM – 12:00 PM at 2AB (Level 2, Seattle Convention Center), Speakers
  • Jonathan Purtle, DrPH, MPH, MSc New York University School of Global Public Health
    • The Future of Mental Health and Substance Use Treatment Services in the United States, 12:30 PM – 2:00 PM PDT at 613-614 (Level 6, Seattle Convention Center), Moderator

Sunday, June 25, 2023

  • Susan Busch, PhD, Yale School of Public Health
    • Digital Health Technologies for Opioid Use Disorder in Accountable Care Organizations: Results from a National Survey, 3:30 PM – 4:45 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
  • Dhruv Khurana, PhD, MS, MA, David Geffen School of Medicine at UCLA
    • Intervening on Community Conditions and Structural Drivers of Health to Realize Individual and Collective Benefits, 5:00 PM – 6:30 PM PDT at 4C-2 (Level 4, Seattle Convention Center), Chair
  • Margaret Lowenstein, MD, MSHP, Co-director, Dissemination & Policy Core, University of Pennsylvania
    • Mobile Service Delivery in Response to the Opioid and HIV Epidemics in Philadelphia, 3:30 PM – 4:45 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
  • Catherine Maclean, PhD, George Mason University
    • Effects of Eliminating Behavioral Health Cost-Sharing on Prescription Drug Use, 11:00 AM – 12:30 PM at 4C-3 (Level 4, Seattle Convention Center), Author
    • Implementation of the New Mexico “No Behavioral Health Cost Sharing Law:” Perceptions of Key Informants, 11:00 AM – 12:30 PM at 4C-3 (Level 4, Seattle Convention Center), Author
  • Harold Pollack, PhD, MPP, University of Chicago School of Social Service Administration
    • The Association of Patient Age and Employment with Treatment Outcomes Among Criminal-Legal-System-Referred Patients in Outpatient Opioid Use Disorder Treatment, 8:00 AM – 9:30 AM at 4C-4 (Level 4, Seattle Convention Center), Author
    • ABLE Accounts for People with Disabilities: Disparities By Income and Disability-Type, 11:00 AM – 12:30 PM at 618 (Level 6, Seattle Convention Center), Presenting Author
  • Daniel Polsky, PhD, Bloomberg Distinguished Professor at the Bloomberg, School of Public Health and the Carey School of Business, Johns Hopkins University
    • Network Breadth for Psychiatrists in Medicare Advantage Is Substantially Narrower Than in Medicaid and ACA Markets, 11:00 AM – 12:30 PM at 4C-3 (Level 4, Seattle Convention Center), Author
  • Jonathan Purtle, DrPH, MPH, MSc New York University School of Global Public Health
    • State-Level Increases in Call Volume to the 988 Suicide and Crisis Lifeline, Associated Cost Estimates, and Earmarked Funding Following the Implementation of 9-8-8, 1:45 PM – 3:15 PM at 618 (Level 6, Seattle Convention Center), Presenting Author
  • Brendan Saloner, PhD, Johns Hopkins Bloomberg School of Public Health
    • Effects of Eliminating Behavioral Health Cost-Sharing on Prescription Drug Use, 11:00 AM – 12:30 PM at 4C-3 (Level 4, Seattle Convention Center), Author
    • Implementation of the New Mexico “No Behavioral Health Cost Sharing Law:” Perceptions of Key Informants, 11:00 AM – 12:30 PM at 4C-3 (Level 4, Seattle Convention Center), Author
  • Theresa Shireman, PhD, MS, Brown University School of Public Health
    • Impact of Acute Myocardial Infarction on Statin Adherence Among Medicaid Beneficiaries in 14 States from 2001 to 2015, 3:30 PM – 4:45 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
  • Cindy Parks Thomas, PhD, Brandeis University Heller School for Social Policy and Management
    • Quality of Opioid Use Disorder Treatment for Persons Covered By Medicaid with and without Disabling Conditions, 8:00 AM – 9:30 AM at 4C-4 (Level 4, Seattle Convention Center), Presenting Author
  • Benjamin Ukert, PhD, Texas A & M University School of Public Health
    • Impact of Telemedicine Licensure Waivers on Interstate Delivery of Telemedicine and Access to Care, 3:30 PM – 4:45 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
  • Todd Wagner, PhD, Stanford University and VA Health, Economics Resource Center
    • Declining Attrition from VA Among New Women Veteran Primary Care Patients, 3:30 PM – 4:45 PM at Hall 4AB (Level 4, Seattle Convention Center), Author

Monday, June 26, 2023

  • Marcus Bachhuber, MD, MSHP, LSU Health Sciences Center
    • Health Services Use Among Formerly Incarcerated Louisiana Medicaid Members within One Year of Release, 1:00 PM – 2:30 PM at 612 (Level 6, Seattle Convention Center), Author
  • Brittany Bass, PhD, UCLA Integrated Substance Abuse Programs
    • The Effect of the Drug Medi-Cal Organized Delivery System on Substance Use Disorder Treatment Access: Evidence from California, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
  • Yuhua Bao, PhD, Investigator, Population Data & Modeling Core, Investigator, Administrative Core, Weill Cornell Medicine
    • Association between Diagnosis Setting and Treatment Initiation Among Medicare Patients with Hepatitis C, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
    • Out-of-Pocket Costs and Initiation of HCV Treatment Among Medicare Beneficiaries Receiving Low-Income Subsidy, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
  • Czarina Behrends, PhD, MPH, Weill Cornell Medicine
    • “a Lot of Us ‘essential’ Workers Could Replace the Word with ‘expendable'”: Perspectives of SSP Staff on Morale during the COVID-19 Pandemic, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
    • Examination of COVID-19 Pandemic Impacts on Syringe Service Program Operations over Time, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Authors
  • Susan Busch, PhD, Yale School of Public Health
    • Impact of the Certified Community Behavioral Health Clinic Demonstration on Availability of Primary Care and Specialty Services in Community Mental Health Settings, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Presenting Author
    • Offering Buprenorphine in Addiction Treatment Facilities: A Decomposition of Entry and Exit Dynamics, Contribution to Change, and the Role of the Comprehensive Addiction and Recovery Act, 2009-2020, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
    • Medicaid ACO Contract Characteristics and the Availability of Substance Use Disorder Treatment: Evidence from a National Survey, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
  • Jason M. Hockenberry, PhD, Yale School of Public Health
    • Impact of the Certified Community Behavioral Health Clinic Demonstration on Availability of Primary Care and Specialty Services in Community Mental Health Settings, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
    • Excluding Observation Stays from Pediatric Quality Measures: Disparities in Measuring Pediatric Preventable Hospitalizations, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
  • Elbert Huang, MD, MPH, University of Chicago
    • Chicago’s Community-Based Participatory Research Ecosystem: A Network Analysis, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
  • Ali Jalali, PhD, MA, Weill Cornell Medicine
    • County-Level Proportion of Independent Vs. Chain Pharmacies and Naloxone Claims in the United States, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
  • Shashi Kapadia, MD, MS, Weill Cornell Medicine
    • “a Lot of Us ‘essential’ Workers Could Replace the Word with ‘expendable'”: Perspectives of SSP Staff on Morale during the COVID-19 Pandemic, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
    • Association between Diagnosis Setting and Treatment Initiation Among Medicare Patients with Hepatitis C, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
    • Examination of COVID-19 Pandemic Impacts on Syringe Service Program Operations over Time, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
    • Out-of-Pocket Costs and Initiation of HCV Treatment Among Medicare Beneficiaries Receiving Low-Income Subsidy, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
  • Dhruv Khurana, PhD, MS, MA, David Geffen School of Medicine at UCLA
    • The Effect of the Drug Medi-Cal Organized Delivery System on Substance Use Disorder Treatment Access: Evidence from California, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Presenting Author
    • The Whole Person Health Score: A Patient-Focused Tool to Measure Nonmedical Determinants of Health, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Presenting Author
  • Noa Krawczyk, PhD, NYU Grossman School of Medicine
    • Narratives of Engaging in Emergency Services, Drug Treatment, and Harm Reduction Services Following Nonfatal Overdose in the COVID-19 Pandemic across States, 1:00 PM – 2:30 PM at 4C-4 (Level 4, Seattle Convention Center), Author
  • Benjamin P. Linas, MD, MPH, Director, Population Data & Modeling Core, Boston Medical Center
    • County-Level Proportion of Independent Vs. Chain Pharmacies and Naloxone Claims in the United States, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
  • Tami Mark, PhD, MBA, RTI International
    • Alcohol Use Disorder in Medicare: Health Consequences and Costs to Medicare, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
    • The Cost of Opioid Use Disorder-Related Conditions in Medicare, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Presenting Author
    • The Effect of a Comprehensive Mental Health Crisis System on Suicide Hospitalizations, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
  • Brandon Marshall, PhD, Brown University School of Public Health
    • Association of Opioid Use Disorder Diagnosis with Use of Physical Therapy and Chiropractic Care Among Chronic Low Back Pain Patients: A Group-Based Trajectory Analysis, 1:00 PM – 2:30 PM at 4C-4 (Level 4, Seattle Convention Center), Author
    • County-Level Proportion of Independent Vs. Chain Pharmacies and Naloxone Claims in the United States, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
  • Jake R. Morgan, PhD, Investigator, Population Data & Modeling Core, Boston University School of Public Health
    • Out-of-Pocket Spending and Healthcare Utilization Patterns Among Individuals Initiating Medications for Opioid Use Disorder: Findings from a Commercially-Insured National Cohort, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
    • County-Level Proportion of Independent Vs. Chain Pharmacies and Naloxone Claims in the United States, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
  • Sean M. Murphy, PhD, Co-director, Methodology Core, Director, Consultation Service, Weill Cornell Medicine
    • County-Level Proportion of Independent Vs. Chain Pharmacies and Naloxone Claims in the United States, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
  • Harold Pollack, PhD, MPP, University of Chicago School of Social Service Administration
    • Evaluating the Impact of Therapeutic Communities in Prisons on Substance-Using Inmates, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Authors
    • The Impact and Cost-Effectiveness of Combined Community and Jail-Based Take-Home Naloxone Distribution to Prevent Opioid Overdose Mortality, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Presenting Author
    • The Way to a Man’s Heart (Disease): Exploring Connections between Male Adherence with Gendered Behavior and Cardiovascular Disease Risk, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
    • Implementation Analysis of Chicago’s Multidisciplinary Crisis Response, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Presenting Author
  • Daniel Polsky, PhD, Bloomberg Distinguished Professor at the Bloomberg, School of Public Health and the Carey School of Business, Johns Hopkins University
    • Avoidable Hospitalizations in Medicare Advantage and Traditional Medicare, and the Role of Provider Networks, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
    • Impact of Medicare Advantage Part B Step Therapy on Drug Utilization: Evidence from Macular Degeneration Drugs, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
  • Brendan Saloner, PhD, Johns Hopkins Bloomberg School of Public Health
    • Narratives of Engaging in Emergency Services, Drug Treatment, and Harm Reduction Services Following Nonfatal Overdose in the COVID-19 Pandemic across States, 1:00 PM – 2:30 PM at 4C-4 (Level 4, Seattle Convention Center), Author
  • Bruce R. Schackman, PhD, MBA, Director, CHERISH, Co-director, Population Data & Modeling Core, Director, Administrative Core, Weill Cornell Medicine
    • Examination of COVID-19 Pandemic Impacts on Syringe Service Program Operations over Time, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Authors
  • Theresa Shireman, PhD, MS, Brown University School of Public Health
    • Association of Opioid Use Disorder Diagnosis with Use of Physical Therapy and Chiropractic Care Among Chronic Low Back Pain Patients: A Group-Based Trajectory Analysis, 1:00 PM – 2:30 PM at 4C-4 (Level 4, Seattle Convention Center), Author
    • Receipt of Gender-Affirming Surgeries Among Medicare Beneficiaries, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Authors
    • Transgender Medicare Beneficiaries Emergency Room Utilization from 2011-2020, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Authors
  • Revathy Suryanarayana, MSc, CHERISH pilot grantee 2022-2023, Cornell University
    • Out-of-Pocket Costs and Initiation of HCV Treatment Among Medicare Beneficiaries Receiving Low-Income Subsidy, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Presenting Author
  • Jeffery Talbert, PhD, University of Kentucky College of Medicine
    • Rural Hospitals Post Lower Gross and Negotiated Prices for Common Services, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
  • Cindy Parks Thomas, PhD, Brandeis University Heller School for Social Policy and Management
    • Substance Use Treatment Services in Medicaid Managed Care Plans: Covered Services and Utilization Management Requirements, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
  • Benjamin Ukert, PhD, Texas A & M University School of Public Health
    • The Corporatization of Independent Hospitals, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Presenting Author
  • Todd Wagner, PhD, Stanford University and VA Health, Economics Resource Center
    • Differences across Race and Ethnicity in the Quality of Antidepressant Medication Management, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Authors
  • Alexander Walley, MD, MSc, Investigator, Population Data & Modeling Core, Boston Medical Center
    • County-Level Proportion of Independent Vs. Chain Pharmacies and Naloxone Claims in the United States, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
  • Xiao Zang, PhD, University of Minnesota
    • County-Level Proportion of Independent Vs. Chain Pharmacies and Naloxone Claims in the United States, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
  • Gary A. Zarkin, PhD, MA, RTI International
    • The Effect of a Comprehensive Mental Health Crisis System on Suicide Hospitalizations, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Presenting Author

Tuesday, June 27, 2023

  • Kevin Callison, PhD, Tulane University School of Public Health & Tropical Medicine
    • Market-Level Spillover Effects of the Medicare Shared Savings Program: Evidence from Movers, 10:30 AM – 12:00 PM at Ballroom 6A (Level 6, Seattle Convention Center), Authors
  • Daniel Hartung, PharmD, MPH, Oregon State University
    • Effect of Integration of Prescription Drug Monitoring Program Data in the Electronic Health Record, 8:30 AM – 10:00 AM at 4C-1 (Level 4, Seattle Convention Center), Presenting Author